Respirion Pharmaceuticals
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
PO Box 214, Joondalup, Western Australia...Website
www.respirionpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Respirion Pharmaceuticals
Respirion Pharma is focused on developing innovative treatments for Cystic Fibrosis lung infections, specifically targeting the disruption of biofilms that protect chronic lung bacterial infections. The company is advancing a novel inhaled treatment that combines a widely used antibiotic with a biofilm disrupting agent, which has shown promising results in improving bacterial clearance and lung function in initial studies. With approximately 70,000 patients affected worldwide, Respirion aims to provide new options for this patient population. Currently, they are conducting a Phase 2 clinical trial for their inhaled therapy, RSP-1502.Explore more
Popular SearchesRespirion PharmaceuticalsSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Respirion Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Respirion Pharmaceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Respirion Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Respirion Pharmaceuticals
Earning: See what the market has to say on Respirion Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Respirion Pharmaceuticals has new funding data
Check if Respirion Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Respirion Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Respirion Pharmaceuticals launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Respirion Pharmaceuticals
Compare insights from companies similar to Respirion Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Respirion Pharmaceuticals
<$5M
1-10
Private
-
-
N/A
Company Profile Activity
Activity Insights
Respirion Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Respirion Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Respirion Pharmaceuticals.
Respirion Pharmaceuticals Tech Stack
A closer look at the technologies used by Respirion Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Respirion Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Respirion Pharma is focused on developing innovative treatments for Cystic Fibrosis lung infections, specifically targeting the disruption of biofilms that protect chronic lung bacterial infections. The company is advancing a novel inhaled treatment that combines a widely used antibiotic with a biofilm disrupting agent, which has shown promising re... Read More
